Current studies have shown that it is highly expressed in the serum of patients with PCOS, and its expression in the serum of three clinical subtypes of PCOS patients—obese IR (OIR), nonobese IR (NOIR), and nonobese non-IR (NIR)—exhibits an increasing trend, indicating that the abnormal expression of the lncRNA MIRLET7BHG is associated with IR and obesity [ 81 ].
← all excerpts
Role and interaction of LncRNAs and insulin resistance in polycystic ovary syndrome: a narrative review.
1
—
—